Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.21.1
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Concentration Risk [Line Items]    
Revenues $ 86,932 $ 88,489
U.S. revenue    
Concentration Risk [Line Items]    
Revenues 71,212 68,406
Non-U.S. revenue    
Concentration Risk [Line Items]    
Revenues $ 15,720 $ 20,083